CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −1,394 | $237.05 | $330K | 143,422 |
| 2025-12-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,050 | $238.13 | $488K | 141,372 |
| 2025-12-01 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −956 | $239.44 | $229K | 140,416 |
| 2025-11-24 | BOTHA ROELOF Director | Sale | −2,000 | $228.97 | $458K | 1,227,198 |
| 2025-11-24 | BOTHA ROELOF Director | Sale | −1,000 | $230.03 | $230K | 1,226,198 |
| 2025-11-24 | BOTHA ROELOF Director | Sale | −900 | $231.23 | $208K | 1,225,298 |
| 2025-11-24 | BOTHA ROELOF Director | Sale | −3,606 | $232.75 | $839K | 1,221,692 |
| 2025-11-24 | BOTHA ROELOF Director | Sale | −7,032 | $233.66 | $1.6M | 1,214,660 |
| 2025-11-24 | BOTHA ROELOF Director | Sale | −9,991 | $234.55 | $2.3M | 1,204,669 |
| 2025-11-24 | BOTHA ROELOF Director | Sale | −9,623 | $235.65 | $2.3M | 1,195,046 |
| 2025-11-24 | BOTHA ROELOF Director | Sale | −6,173 | $236.54 | $1.5M | 1,188,873 |
| 2025-11-24 | BOTHA ROELOF Director | Sale | −15,336 | $237.69 | $3.6M | 1,173,537 |
| 2025-11-24 | BOTHA ROELOF Director | Sale | −18,839 | $238.57 | $4.5M | 1,154,698 |
| 2025-11-24 | BOTHA ROELOF Director | Sale | −500 | $239.11 | $120K | 1,154,198 |
| 2025-11-21 | Sheena Jonathan Director | Sale 10b5-1 | −2,000 | $230.01 | $460K | 23,282 |
| 2025-11-21 | Sheena Jonathan Director | Sale 10b5-1 | −2,000 | $230.01 | $460K | 23,282 |
| 2025-11-20 | Baynes Roy D. Director | Option exercise 10b5-1 | +600 | $40.93 | $25K | 18,959 |
| 2025-11-20 | Baynes Roy D. Director | Option exercise 10b5-1 | +7,068 | $41.19 | $291K | 26,027 |
| 2025-11-20 | Baynes Roy D. Director | Sale 10b5-1 | −1,184 | $220.14 | $261K | 24,843 |
| 2025-11-20 | Baynes Roy D. Director | Sale 10b5-1 | −900 | $221.81 | $200K | 23,943 |
Page 32 of 39 · 767 trades